• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Clene Inc. - Common Stock (NQ:CLNN)

    4.100 +0.020 (+0.49%)
    Streaming Delayed Price Updated: 3:55 PM EDT, Jun 13, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 70,856
    Open 4.030
    Bid (Size) 4.110 (19)
    Ask (Size) 4.320 (6)
    Prev. Close 4.080
    Today's Range 4.018 - 4.250
    52wk Range 2.280 - 8.598
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
    Via Stocktwits
    Study Finds Kids with MS Biologically Age Faster Than Those Without It
    Via Investor Brand Network

    Performance

    YTD
    -23.9%
    -23.9%
    1 Month
    +54.1%
    +54.1%
    3 Month
    -7.4%
    -7.4%
    6 Month
    -17.2%
    -17.2%
    1 Year
    -48.2%
    -48.2%

    More News

    Read More
    InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Rob Etherington to Present at June 10 Investor Summit Virtual
    Via Investor Brand Network
    Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025
    Via ACCESS Newswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Study Links Autism to Increased Risk of Developing Parkinson’s Disease
    Via Investor Brand Network
    Researchers Discover Potential Missing Connection Between EBV and Multiple Sclerosis
    Via Investor Brand Network
    Eye Exam Could Help in Detecting Parkinson’s Disease Early, Study Suggests
    Via Investor Brand Network
    BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Reports Q1 Results, Advances CNM-Au8 Toward Potential Accelerated Approval for ALS
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Participate in D. Boral Capital Global Conference on May 14
    Via Investor Brand Network
    Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development
    Via Investor Brand Network
    InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Evidence of Remyelination, Cognitive and Visual Gains in MS Trial
    Via Investor Brand Network
    Study Suggests Possible Link Between ADHD and Heightened Dementia Risk
    Via Investor Brand Network
    Clene Inc. (NASDAQ: CLNN) to Share CNM-Au8(R) Progress at Jones Las Vegas Conference
    Via Investor Brand Network
    Exposures Product Safety
    InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovation Conference on April 9
    Via Investor Brand Network
    Clene Inc.’s (NASDAQ: CLNN) Q1 Virtual Investor Summit Presentation Available for On-Demand Viewing
    Via Investor Brand Network
    New Study Finds Possible Explanation for Higher Parkinson’s Prevalence in Men
    Via Investor Brand Network
    InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Las Vegas Technology and Innovation Conference
    Via Investor Brand Network
    Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
    Via TheNewswire.com
    Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
    Via NewMediaWire
    BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Plans 2025 NDA Submission Following Positive ALS Trial Data
    Via Investor Brand Network
    Exposures Product Safety
    BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Unveils Progress on CNM-Au8(R), Eyes Potential Fast-Track FDA Approval
    Via Investor Brand Network
    Exposures Product Safety
    Clene Inc.’s (NASDAQ: CLNN) CNM-Au8(R) Delivers Significant Survival Benefits in New Analyses of Healey ALS Platform Trial Data
    Via Investor Brand Network

    Frequently Asked Questions

    Is Clene Inc. - Common Stock publicly traded?
    Yes, Clene Inc. - Common Stock is publicly traded.
    What exchange does Clene Inc. - Common Stock trade on?
    Clene Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Clene Inc. - Common Stock?
    The ticker symbol for Clene Inc. - Common Stock is CLNN on the Nasdaq Stock Market
    What is the current price of Clene Inc. - Common Stock?
    The current price of Clene Inc. - Common Stock is 4.100
    When was Clene Inc. - Common Stock last traded?
    The last trade of Clene Inc. - Common Stock was at 06/13/25 03:55 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.